Chemotherapy regimen | Total n = 96 | Complying group n = 58 | Non-complying group n = 38 |
---|---|---|---|
5-flourouracil | 1 | 1 | 0 |
ABVD | 2 | 0 | 2 |
AC | 7 | 6 | 1 |
Bendamustine | 3 | 0 | 3 |
B-mab+CBDCA+PAC | 1 | 1 | 0 |
B-mab+mFOLFOX6 | 3 | 2 | 1 |
CBDCA+GEM | 2 | 2 | 0 |
CBDCA+VP16 | 2 | 2 | 0 |
CHOP | 5 | 1 | 4 |
DeVIC | 2 | 1 | 1 |
DOC | 2 | 0 | 2 |
DOXIL | 2 | 2 | 0 |
GC | 1 | 1 | 0 |
GEM | 12 | 12 | 2 |
High dose-AraC | 2 | 0 | 2 |
Hign dose MTX | 2 | 0 | 2 |
Irinotecan | 2 | 2 | 0 |
Pemetrexed + CBDCA | 3 | 3 | 0 |
Pemetrexed | 1 | 1 | 0 |
PAC+GEM | 2 | 2 | 0 |
R-CHOP | 3 | 0 | 3 |
Rituximab | 1 | 1 | 0 |
R-THPCOP | 10 | 4 | 6 |
S1+DOC | 2 | 2 | 0 |
S1+CDDP | 1 | 1 | 0 |
S1+GEM | 8 | 6 | 2 |
SOX | 4 | 1 | 3 |
THPCOP | 2 | 0 | 2 |
VNR + HER | 1 | 0 | 1 |
CBDCA+PAC | 1 | 1 | 0 |
Weekly PAC | 1 | 1 | 0 |
Weekly PAC+ HER | 2 | 1 | 1 |